In urology, we have a saying: an erection is a barometer. What it measures is the health of the vascular and metabolic systems years before standard cardiology screening would catch a problem. Men who present with new-onset erectile dysfunction in their 40s and 50s frequently turn out to have undiagnosed insulin resistance, prediabetic glucose patterns, or early endothelial dysfunction — not yet diabetes, not yet heart disease, but well on the way. The conversation about ED in 2026 increasingly cannot be separated from the conversation about metabolic health.
From Dr. Robbins' PracticeI order a metabolic workup on essentially every man who comes in with new ED. Fasting insulin, fasting glucose, HbA1c, lipid panel, hsCRP. About half the time, we find something. Not always full-blown disease — often the early patterns that respond beautifully to focused intervention. Treating those metabolic patterns sometimes resolves the ED without any urological treatment at all. This is the conversation more men should be having.
Why an Erection Depends on Metabolic Health
An erection is a vascular event. When sexual arousal triggers the nervous system, signals reach the penis and tell the smooth muscle of the corpora cavernosa to relax. As the muscle relaxes, blood flows in. The resulting pressure compresses the venous outflow channels, trapping the blood inside, which produces and maintains rigidity. The whole process depends on healthy endothelium — the lining of the blood vessels — and on the nitric oxide signaling that allows the endothelium to mediate vasodilation.
Insulin resistance damages this system through several mechanisms. Chronically elevated insulin levels promote inflammation in the vascular endothelium. Elevated glucose damages the inner lining of blood vessels directly through glycation. The combination reduces the bioavailability of nitric oxide — the same molecule that's the target of Viagra. Men with insulin resistance often have ED for the same reason they will eventually have cardiovascular disease: the small blood vessels are losing their ability to relax on demand.
The penile arteries are small — about 1–2 millimeters in diameter. The coronary arteries are larger, about 3–4 millimeters. This is part of why ED frequently presents 3–5 years before a cardiac event in men with metabolic disease — the smaller vessels fail first.
The Insulin-Endothelium Axis in Plain English
A simplified version of the cascade:
A man eats more refined carbohydrate than his body can efficiently process. His pancreas releases insulin to clear the glucose from his bloodstream. Over years, his cells become less responsive to insulin's signal. To compensate, the pancreas releases more insulin. The man becomes hyperinsulinemic — chronically high insulin — while his blood glucose may still look normal on a standard fasting test.
In parallel, the chronic elevated insulin promotes inflammation throughout the vasculature. The endothelium becomes less responsive. Nitric oxide signaling is impaired. The small blood vessels — including those of the penis — can no longer dilate normally on demand.
Erectile dysfunction emerges. The man may be 45, otherwise healthy-looking, normal weight, with a "normal" fasting glucose and unremarkable cholesterol panel. Standard screening misses what's happening. The vascular damage is real but quiet.
What This Looks Like in Practice
A typical pattern: a man in his late 40s presents with gradual-onset ED — not sudden, no clear psychological trigger, no obvious vascular event. His standard fasting glucose is in the high-normal range (95–105 mg/dL). His HbA1c is 5.5 or 5.6 — technically normal. His cholesterol is mildly elevated but not "treatment threshold." He is not diabetic, not obviously sick.
A more sensitive workup — fasting insulin, HOMA-IR calculation, glucose response after a meal, hsCRP — often shows the pattern that the standard panel misses. Fasting insulin in the high single or double digits when it should be under 5. HOMA-IR above 2. Elevated inflammatory markers. This is metabolic dysfunction that hasn't yet declared itself as diabetes but is already driving vascular changes.
Continuous Glucose Monitors: A New Tool
In 2026, continuous glucose monitors (CGMs) — small wearable sensors that track interstitial glucose in real time — have moved from a tool for diabetics to a tool for proactive metabolic optimization. Brands like Levels, Stelo, and Dexcom Stelo are accessible without a prescription in much of the U.S. Worn for a few weeks, a CGM reveals an individual's actual glucose response to specific meals, sleep, stress, and exercise.
For men with unexplained ED, CGM data can be revelatory. Men assume their diet is fine because the foods feel reasonable; the CGM shows that breakfast spikes glucose to 180 and keeps it elevated for two hours. Or that the late-night meal blunts overnight glucose recovery. Or that a particular drink spikes harder than expected.
A CGM is not a diagnostic tool for ED. It is a feedback tool for the work of metabolic optimization. Men who use one alongside lifestyle changes — reduced refined carbohydrate, earlier dinners, strength training, sleep prioritization — tend to make meaningful changes faster than men working blind. As metabolic health improves, vascular function typically improves with it. ED often follows.
The Lifestyle Levers That Move the Needle
Strength Training
Resistance training is the single most evidence-backed intervention for insulin sensitivity in middle-aged men. Building skeletal muscle creates more glucose-disposal capacity. Two or three sessions a week focused on compound lifts — squats, deadlifts, presses, rows — has more measurable impact on metabolic health than most pharmacological interventions short of GLP-1s.
Sleep Architecture
A single night of poor sleep measurably reduces insulin sensitivity the following day. Chronic short or fragmented sleep is one of the most underappreciated drivers of metabolic dysfunction in otherwise health-conscious men. Improvements in sleep duration and quality often improve glucose regulation more quickly than dietary changes.
Earlier and Smaller Last Meal
Time-restricted eating — concentrating food intake earlier in the day, with a clear gap before sleep — reliably improves metabolic markers in studies. The mechanism is partly circadian (insulin sensitivity is higher in the morning), partly about sleep quality, and partly about absolute caloric pattern.
Carbohydrate Quality and Quantity
For most men with metabolic dysfunction, reducing refined carbohydrate is more impactful than reducing total calories. Whole-food carbohydrate — vegetables, beans, intact grains, fruit — is metabolically very different from processed carbohydrate sources. The CGM makes this concrete in a way that food-tracking apps never quite did.
Walking After Meals
A 10–15 minute walk after a meal blunts the glucose spike significantly. Across a week of meals, this accumulates into a meaningful effect on average glucose, fasting insulin, and downstream metabolic markers.
Where Targeted Treatment Still Fits
Lifestyle intervention is the foundation, not the only answer. For men with established ED while metabolic work is underway, several treatments remain available and effective: PDE5 inhibitors (Viagra, Cialis) work directly on the nitric oxide pathway and can restore function while the underlying vascular health improves. Low-intensity shockwave therapy can promote angiogenesis — new blood vessel growth — in the penile vasculature. PRP and exosome therapy offer regenerative approaches that work in parallel with metabolic optimization.
A comprehensive treatment plan often combines targeted therapy with metabolic work, with the targeted therapy improving function in the near term while lifestyle and metabolic changes address the underlying cause. Men who do both often see better long-term outcomes than men who pursue either path alone.
When to Ask Your Doctor for Better Testing
If you have ED and your standard labs are "normal," ask for the following additions:
Fasting insulin — not just fasting glucose. A fasting insulin above 7–8 mIU/L often precedes any change in glucose by years.
HOMA-IR — a calculation from fasting insulin and fasting glucose that estimates insulin resistance.
HbA1c — a 90-day average of blood glucose. Even within the "normal" range, the upper end (5.5–5.7) is associated with measurable cardiovascular risk.
hsCRP — high-sensitivity C-reactive protein, a marker of systemic inflammation. Often elevated in metabolic dysfunction before standard glucose markers move.
Lipid panel with apoB — apoB is a more accurate vascular risk marker than total cholesterol or LDL alone.
Testosterone (total and free) — low testosterone interacts with metabolic health in both directions. Signs of low T often overlap with metabolic dysfunction, and treating one can improve the other.
The Bottom Line
Erectile dysfunction in 2026 deserves a metabolic workup. Not because every case is metabolic in origin — many aren't — but because a meaningful subset is, and those men benefit dramatically from being identified early. A targeted ED treatment plan that ignores underlying metabolic dysfunction is treating the symptom while the disease continues to progress. The same lifestyle and metabolic work that protects sexual function tends to protect against the cardiovascular events that come later. ED is not just an issue to fix — it is, for many men, a signal worth listening to.
At INTIMÉ Miami, Dr. David Robbins offers comprehensive sexual medicine evaluations that include metabolic and hormonal workup alongside urological assessment. Schedule a confidential consultation to discuss your full picture, not just your symptoms.
Written by Dr. David Robbins — Board-Certified Urologist and Medical Director of INTIMÉ Miami.